Acurian Doubles the Site Enrollment Rate for a Sarcopenia Clinical Trial to Save Three Months of Enrollment

Musculoskeletal

Sarcopenia

A top-10 pharmaceutical company initiated a Phase III clinical trial to evaluate its compound’s ability to increase muscle mass and strength and improve mobility in older adults with sarcopenia.

Read More »